ReviewBlood advances2023
Applying CRISPR-Cas9 screens to dissect hematological malignancies.
Deepak Narayanan Iyer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it
ReviewBlood advances2023
Deepak Narayanan Iyer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.